Exosome tools

Extracellular vesicles (EVs) are ideal candidates for developing and testing new drug delivery methods as they can cross biological barriers such as the blood-brain barrier and get internalised into cells with a high degree of specificity. The natural properties of EVs enable their forward engineering and further refinement to make EVs carrying specific drug candidates to target specific molecular pathways, cells and tissues.

Cambridge Bioscience has partnered with System Biosciences (SBI) and Cell Guidance Systems to offer high-quality tools to accelerate exosome-based discoveries for therapeutic delivery. The portfolio includes solutions compatible with a wide range of biofluids for exosome isolation, characterisation, quantitation, visualisation and biomarker discovery services including next-generation sequencing (NGS) and proteomic profiling.